Krishna Institute Of Medical Sciences Limited · NSE:KIMS
Krishna Institute Of Medical Sciences — Q3 FY2025 Earnings Presentation
34 slides from Krishna Institute Of Medical Sciences's earnings presentation, Feb 6, 2025
Slide 1: Letter to stock exchanges: Investor Presentation
06th February 2025 The General Manager, The Manager, Department of Corporate Services Listing Department Bombay Stock Exchange Ltd (BSE) National Stock Exchange of India Limited, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No.C/1, 'G' Block, Mumbai - 400 001. Bandra -
Slide 2: Q3 FY25 Update
Q3 FY25 UPDATE Private & Confidential
Slide 3: Driven by a Vision
Driven by a Vision Affordable Quality Care VISION: Best-in-Class Facilities Patient Centric Systems & Processes S To be the most preferred NT healthcare services brand by TIE providing affordable care and best PA clinical outcomes to patients. Clinical Outcome Driven Excellence And to be the best pl
Slide 4: Multi Specialty Care
Multi Specialty Care Brain Eyes Bones and Spine Radiology • Neurology • Ophthalmology • Orthopedics • Imaging • Neurosurgery Gastro Intestinal Tract • Arthroscopic Surgery • Interventional Radiology • Psychiatry • Medical Gastroenterology • Spine Surgery Lab Services • Neuro Rehabilitation • Surgica
Slide 5: KIMS at a Glance
KIMS at a Glance Telangana Secunderabad (1000) Maharashtra Begumpet (290) Nagpur (334) Kondapur (200) + 500 beds under construction Nashik (325) Gachibowli (237) Thane (300) - Under Construction Asian Transcare (60) MIPPL (10) Karnataka Andhra Pradesh Bengaluru Vizag (KIMS ICON: 434) Soulspace (450)
Slide 6: Dr. B. Bhaskar Rao - Visionary Behind KIMS
Dr. B. Bhaskar Rao - Visionary Behind KIMS Chairman & Managing Director A legend in CT Surgery, Dr. Bollineni Bhaskar Rao {MBBS, MS, DNB (CT Surgery)} is one of the very few Cardio- Thoracic Surgeons in the country, who performed over 30000 surgeries in his career spanning over more than 25 years. W
Slide 7: Dr. Abhinay Bollineni
Dr. Abhinay Bollineni Chief Executive Officer Dr. Abhinay Bollineni joined KIMS Hospitals in 2013 and spent the next couple of years in Hospital Operations before taking charge of Strategy & Marketing for the Group in 2015. He was appointed as the CEO in 2019. Dr. B. Abhinay completed MBBS from the
Slide 8: Board of Directors
Board of Directors Dr. Bhaskara Rao Bollineni Dr. Abhinay Bollineni Mrs. Anitha Dandamudi Mr. Saumen Chakraborty Chairman & Managing Director Chief Executive Officer Whole-time Director Independent Director, Chairman (Audit Committee) Mr. Adwik Bollineni Mr. Venkata Ramudu Jasthi Mrs. Y. Prameela Ra
Slide 9: Shareholding Pattern - As on 31 December, 2024
Shareholding Pattern - As on 31 December, 2024 st Retail & Others, Retail Pre IPO, 4.3% 7.0% Promoter & Promoter Share Holder No of Shares Share Holding % Category Group, 38.8% Promoter 15,52,56,520 38.8% SBI MF 2,82,52,920 7.1% DII HDFC MF 1,86,50,706 4.7% DII FII, 17.3% Axis MF 1,76,99,810 4.4% DI
Slide 10: Modern Medical Technology
Modern Medical Technology 4-Arm HD da Vinci MrGFUS Focussed Other Key Equipments Robotic Surgical Ultrasound System Revolutionary Knifeless Brain • O-Arm Scanner Facilitates complex surgeries procedure for treating tremors. • Spy Glass that are virtually scarless. Proven to reduce Tremors • Fibrosca
Slide 11: MrGFUS Focussed Ultrasound for Tremors
MrGFUS Focussed Ultrasound - A Boon for Tremor Dominant Parkinson's & Essential Tremor in patients First set of patients successfully treated with 100% success rate. • With the recent acquisition of MRI-Guided Focused Ultrasound, we now offer a revolutionary, non-invasive treatment for Essential Tre
Slide 12: Latest da Vinci Robots operational in 4 units
Latest da Vinci Robots operational in 4 units - Secunderabad, Kondapur, Nagpur & Kannur Latest Da Vinci X System at KIMS Hospitals This advanced technology is now empowering our departments: • Surgical Gastroenterology • Pediatric Surgery • Gynecology • Urology • Thoracic Surgery • Surgical Oncology
Slide 13: Many Firsts...
Many Firsts... • First in Asia in to do Trans catheter • India’s first COVID Double Lung • Number 1 in Nephrology treatments in Tricuspid Valve replacement transplant done in 2020 Andhra Pradesh* procedure done in 2018 • India’s first Breathing Lung transplant • Number 1 in Neurosurgery & Poly • Lar
Slide 14: Key Accomplishments
Key Accomplishments NAL ACCRED TIO IT NA AT ER ION INT QU Y ET LI AF A TY & PAT I E N T S Pharmacie De Qualite (PDQ) American Accreditation Commission Certification Overall PDQ Evaluation ‘Best Patient Friendly Hospital’ NABH Digital Standards Accreditation Ranked No. 1 Hospital International (AACI)
Slide 15: Consistent Performer over 2 decades
Consistent Performer over 2 decades (Rupees in Millions) 25,112 6,232 22,235 5,766 % .1% : 2 7.1 16,711 : 3 0 5,217 R CAG GR CA 11,287 2,412 4,280 773 1,311 317 263 42 2005 2010 2015 2020 2022 2023** 2024 2005 2010 2015 2020 2022*** 2023** 2024 No. of No. of No. of No. of No. of No. of No. of Hospit
Slide 16: Q3 FY25 Updates
Q3 FY25 Updates 15 Private & Confidential
Slide 17: Financial & Operational Highlights - 1/2
Financial & Operational Highlights - 1/2 (Rupees in Cr) FINANCIAL HIGHLIGHTS Q3 FY 25 Consolidated • Gross revenue of INR 790 Cr, a growth of 29.7% on YoY and 1.0% on QoQ basis. • EBITDA of INR 205 Cr, a growth of 36.4% on YoY and de growth of 8.1% on QoQ basis. • EBITDA margin at 25.9% vs. 24.7% in
Slide 18: Financial & Operational Highlights - 2/2
Financial & Operational Highlights - 2/2 OPERATIONAL Q3 FY 25 Consolidated HIGHLIGHTS • ARPOB grew by 25.2% and 0.5% on YoY and QoQ basis respectively • ARPP grew by 12.2% and 2.8% on YoY and QoQ basis respectively • IP Volume grew by 13.8% and degrew by 3.1% on YoY and QoQ basis respectively FY25 Q
Slide 19: Group Operating Performance - 1/2
Group Operating Performance - 1/2 IP VOLUME (‘000) OP VOLUME (‘000) 10.1% (3.1%) 14.1% (0.8%) 159 56 54 1,366 474 470 47 392 145 1,197 9M FY24 9M FY25 Q3 FY24 Q2 FY25 Q3 FY25 9M FY24 9M FY25 Q3 FY24 Q2 FY25 Q3 FY25 OCCUPANCY* ARPOB (‘000) 0.5% (10.1%) (6.1%) 23.1% 62.3% 61.6% 38.4 38.3 38.5 56.8% 31
Slide 20: Group Operating Performance - 2/2
Group Operating Performance - 2/2 Particulars FY24 9M FY24 9M FY25 Q3 FY24 Q2 FY25 Q3 FY25 Bed Capacity 3,975 3,975 4,859 3,975 4,610 4,859 Operational Beds 3,503 3,503 4,342 3,503 4,038 4,342 Census Beds 2,989 2,989 3,768 2,989 3,524 3,768 Non Census Beds 514 514 574 514 514 574 Occupied Beds 2,148
Slide 21: Group Financial Performance
Group Financial Performance (Rupees in Millions) TOTAL REVENUE EBITDA (8.1%) 1.0% 20.9% 24.8% 22,655 7,902 6,121 2,231 7,823 2,050 18,735 6,091 4,906 1,503 9M FY24 9M FY25 Q3 FY24 Q2 FY25 Q3 FY25 9M FY24 9M FY25 Q3 FY24 Q2 FY25 Q3 FY25 PBT (17.0%) PAT (23.4%) 17.9% 16.7% 4,240 1,622 3,087 1,207 3,59
Slide 22: Operational and Financial Performance - 1/2
Operational and Financial Performance - 1/2 Telangana Andhra Pradesh Particulars FY24 9M FY24 9M FY25 Q3 FY24 Q2 FY25 Q3 FY25 FY24 9M FY24 9M FY25 Q3 FY24 Q2 FY25 Q3 FY25 Bed Capacity 1727 1727 1797 1727 1737 1797 1914 1914 2214 1914 2214 2214 Operational Beds 1612 1612 1682 1612 1622 1682 1641 1641
Slide 23: Operational and Financial Performance - 2/2
Operational and Financial Performance - 2/2 Maharashtra Kerala Group Particulars FY24 9M FY24 9M FY25 Q3 FY24 Q2 FY25 Q3 FY25 9M FY25 Q3 FY25 FY24 9M FY24 9M FY25 Q3 FY24 Q2 FY25 Q3 FY25 Bed Capacity 334 334 659 334 659 659 189 189 3975 3975 4859 3975 4610 4859 Operational Beds 250 250 630 250 575 6
Slide 24: Speciality Mix
Speciality Mix Others Cardiac Sciences 22% 17% Renal Sciences 9% Mother & Child 10% Group 9M FY25 Organ Oncology Transplant 6% 3% Gastric Sciences 9% Neuro Sciences 10% Orthopaedics 14% 23 Private & Confidential
Slide 25: Payor & Cluster Profile
Payor & Cluster Profile PAYOR MIX CLUSTER TOTAL REVENUE Maharashtra Kerala 1% 7% Aarogyasri Andhra Pradesh 6% 27% Cash Telangana Corporate Group 65% 13% 53% 9M FY25 Group 9M FY25 CLUSTER EBITDA Maharashtra Insurance 3% 28% Andhra Pradesh 24% Group Telangana 73% 9M FY25 1) Telangana - Secunderabad, K
Slide 26: Key Achievements in Q3 FY25
Key Achievements in Q3 FY25 25 Private & Confidential
Slide 27: Key Achievements in Q3 FY25
Key Achievements in Q3 FY25 26 Private & Confidential
Slide 28: Key to our success
Key to our success Doctor Affordable Partnerships Quality Care Modern Medical Infra 27 Private & Confidential
Slide 29: Expansion plans
Expansion plans Current Incremental Approx. Expected Year of Revised Expected Units New Departments Beds Beds Capex Operation Year of Operation Bangalore (Project-1) - 450 All Specialities 350-400 Cr Q4 FY25 Q1 FY26 Bangalore (Project-2) - 350 All Specialities 180-200 Cr Q4 FY25 Q2 FY26 Mumbai (Than
Slide 30: KIMS Valiyath Hospital, Kollam
KIMS Valiyath Hospital, Kollam About Kollam: Kollam, is an ancient seaport and the fourth largest city in the Indian state of Kerala. Located on the southern tip of the Malabar Coast of the Arabian Sea, the city is on the banks of Ashtamudi Lake and is 71 kms northwest of the Thiruvananthapuram. As
Slide 31: Nashik Unit - Now fully operational
Nashik Unit - Now fully operational 30 Private & Confidential
Slide 32: Profit and Loss Statement
Profit and Loss Statement (Rupees in Millions) Consolidated Particulars Q3 FY24 Q2 FY25 Q3 FY25 QoQ(%) YoY(%) 9M FY24 9M FY25 YoY(%) Operating Revenue 6,058 7,773 7,724 -0.6% 27.5% 18,643 22,381 20.1% Other Income 33 50 178 256.0% 439.4% 92 274 197.8% Total Revenue 6,091 7,823 7,902 1.0% 29.7% 18,73
Slide 33: Corporate Structure (As on 31 December'24)
Corporate Structure (As on 31 December'24) st Krishna Institute of Medical Sciences Limited KIMS Secunderabad KIMS Nellore KIMS Rajahmundry KIMS Ongole KIMS Hospitals KIMS QNRI KIMS Swastha (100%) (100%) (100%) (100%) Bengaluru Visakhapatnam Kerala (100%) (100.0%) (100.0%) Doctor Partnership Hospita
Slide 34: Thank You
Thank You 33 Private & Confidential
Krishna Institute of Medical Sciences — Q3 FY2025 Earnings Presentation on 6ix